651 related articles for article (PubMed ID: 12091179)
1. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema.
Turato G; Zuin R; Miniati M; Baraldo S; Rea F; Beghé B; Monti S; Formichi B; Boschetto P; Harari S; Papi A; Maestrelli P; Fabbri LM; Saetta M
Am J Respir Crit Care Med; 2002 Jul; 166(1):105-10. PubMed ID: 12091179
[TBL] [Abstract][Full Text] [Related]
2. [Interleukin-17 expression and significance in normal lung function smokers and chronic obstructive pulmonary disease patients].
Zhang JQ; Lao QF; Chu SY; Bai J; Zhong XN
Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1431-5. PubMed ID: 20646637
[TBL] [Abstract][Full Text] [Related]
3. [The clinical characteristics of intra-acinar pulmonary artery inflammation and its effect on clinical parameters in smokers with normal lung function and patients with chronic obstructive pulmonary disease].
Lao QF; Zhong XN; He ZY; Liu GN; Lü ZL; Wan P
Zhonghua Nei Ke Za Zhi; 2011 Oct; 50(10):839-44. PubMed ID: 22321324
[TBL] [Abstract][Full Text] [Related]
4. Mast cell infiltration discriminates between histopathological phenotypes of chronic obstructive pulmonary disease.
Ballarin A; Bazzan E; Zenteno RH; Turato G; Baraldo S; Zanovello D; Mutti E; Hogg JC; Saetta M; Cosio MG
Am J Respir Crit Care Med; 2012 Aug; 186(3):233-9. PubMed ID: 22679009
[TBL] [Abstract][Full Text] [Related]
5. Reduced apoptosis of CD8+ T-lymphocytes in the airways of smokers with mild/moderate COPD.
Siena L; Gjomarkaj M; Elliot J; Pace E; Bruno A; Baraldo S; Saetta M; Bonsignore MR; James A
Respir Med; 2011 Oct; 105(10):1491-500. PubMed ID: 21612902
[TBL] [Abstract][Full Text] [Related]
6. A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family.
Polverino F; Baraldo S; Bazzan E; Agostini S; Turato G; Lunardi F; Balestro E; Damin M; Papi A; Maestrelli P; Calabrese F; Saetta M
Am J Respir Crit Care Med; 2010 Oct; 182(8):1011-9. PubMed ID: 20581172
[TBL] [Abstract][Full Text] [Related]
7. [The changes and significance of interleukin-16 and CXC chemokine receptor 3 expression in pulmonary artery of smokers with chronic obstructive pulmonary disease].
Wan P; Zhong XN; He ZY; Zhang JQ; Liu GN; Lao QF
Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):841-5. PubMed ID: 20079227
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of CD4+IL-17+ cells in the lung tissue of patients with stable chronic obstructive pulmonary disease (COPD) and smokers.
Zhang J; Chu S; Zhong X; Lao Q; He Z; Liang Y
Int Immunopharmacol; 2013 Jan; 15(1):58-66. PubMed ID: 23127823
[TBL] [Abstract][Full Text] [Related]
9. Influence of smoking cessation on airway T lymphocyte subsets in COPD.
Roos-Engstrand E; Ekstrand-Hammarström B; Pourazar J; Behndig AF; Bucht A; Blomberg A
COPD; 2009 Apr; 6(2):112-20. PubMed ID: 19378224
[TBL] [Abstract][Full Text] [Related]
10. Increased intraepithelial T-cells in stable COPD.
Löfdahl MJ; Roos-Engstrand E; Pourazar J; Bucht A; Dahlen B; Elmberger G; Blomberg A; Sköld CM
Respir Med; 2008 Dec; 102(12):1812-8. PubMed ID: 18706796
[TBL] [Abstract][Full Text] [Related]
11. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers.
Glader P; von Wachenfeldt K; Löfdahl CG
Respir Med; 2006 Jun; 100(6):1088-93. PubMed ID: 16246539
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease.
Santos S; Peinado VI; Ramirez J; Morales-Blanhir J; Bastos R; Roca J; Rodriguez-Roisin R; Barbera JA
Am J Respir Crit Care Med; 2003 May; 167(9):1250-6. PubMed ID: 12615615
[TBL] [Abstract][Full Text] [Related]
13. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview.
Di Stefano A; Caramori G; Ricciardolo FL; Capelli A; Adcock IM; Donner CF
Clin Exp Allergy; 2004 Aug; 34(8):1156-67. PubMed ID: 15298554
[TBL] [Abstract][Full Text] [Related]
14. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.
Kranenburg AR; de Boer WI; Alagappan VK; Sterk PJ; Sharma HS
Thorax; 2005 Feb; 60(2):106-13. PubMed ID: 15681497
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory cells and chronic obstructive pulmonary disease.
Tetley TD
Curr Drug Targets Inflamm Allergy; 2005 Dec; 4(6):607-18. PubMed ID: 17305517
[TBL] [Abstract][Full Text] [Related]
16. Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers.
Löfdahl JM; Wahlström J; Sköld CM
Clin Exp Immunol; 2006 Sep; 145(3):428-37. PubMed ID: 16907910
[TBL] [Abstract][Full Text] [Related]
17. Disease of the airways in chronic obstructive pulmonary disease.
Cosio Piqueras MG; Cosio MG
Eur Respir J Suppl; 2001 Dec; 34():41s-49s. PubMed ID: 12392034
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of the small airways in chronic obstructive pulmonary disease.
Baraldo S; Turato G; Saetta M
Respiration; 2012; 84(2):89-97. PubMed ID: 22868355
[TBL] [Abstract][Full Text] [Related]
19. Distribution of γδ and other T-lymphocyte subsets in patients with chronic obstructive pulmonary disease and asthma.
Urboniene D; Babusyte A; Lötvall J; Sakalauskas R; Sitkauskiene B
Respir Med; 2013 Mar; 107(3):413-23. PubMed ID: 23273406
[TBL] [Abstract][Full Text] [Related]
20. Increased galectin-3 expression and intra-epithelial neutrophils in small airways in severe COPD.
Pilette C; Colinet B; Kiss R; André S; Kaltner H; Gabius HJ; Delos M; Vaerman JP; Decramer M; Sibille Y
Eur Respir J; 2007 May; 29(5):914-22. PubMed ID: 17251233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
